What Is A Biopatch Used For In Infection Prevention?

A biopatch is a small antimicrobial disc placed over the insertion site of a central venous catheter. It releases chlorhexidine gluconate slowly over several days to reduce the risk of catheter-related bloodstream infections.

The device is not a bandage and not a drug in the usual sense. It sits between the skin and the catheter dressing, delivering a measured amount of antiseptic directly where bacteria most often enter the bloodstream. Hospitals use it as one part of a broader strategy to prevent infections that can be serious and sometimes fatal.

What Is a Biopatch Used For in Infection Prevention?

A biopatch is used to lower the chance that bacteria will travel along a catheter and into the bloodstream. Central venous catheters are plastic tubes placed in large veins — often in the neck, chest, or groin — to deliver medications, fluids, or nutrition over days or weeks. The skin around the insertion point is a common entry route for bacteria.

The biopatch works by continuous release of chlorhexidine gluconate, an antiseptic that disrupts bacterial cell membranes. The disc is placed with its foam side down against clean, dry skin, directly around the catheter. It stays in place under the sterile dressing and is typically changed when the dressing is changed.

This matters because bloodstream infections linked to central lines are among the most preventable hospital-acquired infections. They can lead to sepsis, longer hospital stays, and higher mortality. The biopatch is one tool in a bundle of practices that together reduce these risks. No single device eliminates the problem.

How Does a Chlorhexidine Biopatch Actually Work?

Chlorhexidine gluconate binds to the skin and to bacterial cells. It damages the bacterial cell wall, causing the contents to leak out and the organism to die. Unlike antibiotics, which target specific bacterial functions, chlorhexidine acts broadly against many bacteria, some fungi, and certain viruses.

The biopatch is designed to release chlorhexidine slowly. This sustained release keeps a steady concentration of the antiseptic at the skin-catheter interface for several days. That is important because bacteria can regrow on skin within hours after a single cleaning.

The disc itself is made of a foam material that absorbs moisture and holds the antiseptic. The catheter sits in a small slit in the disc, so the antimicrobial agent surrounds the insertion site. The patch does not enter the vein. It acts only on the skin surface and the immediate area around the catheter.

One detail that is often misunderstood: the biopatch does not sterilize the skin. It reduces bacterial load. Sterile technique during insertion and ongoing care remains the foundation of prevention.

Who Should Not Use a Chlorhexidine Biopatch?

Chlorhexidine patches are not appropriate for everyone. The main concern is allergic reaction. Some people develop contact dermatitis — redness, itching, or blistering — after exposure to chlorhexidine. True anaphylaxis is rare but has been reported.

Neonates and infants require special caution. Their skin is thinner and more permeable, and cases of severe skin irritation or chemical burns have been reported with chlorhexidine use in very small or premature infants. Clinical guidance for this population is not uniform, and some hospitals use diluted solutions or avoid chlorhexidine entirely in the smallest babies. No single standard dose or product exists for all neonatal situations.

People with known chlorhexidine allergy should not use the patch. If a patient has had a reaction to chlorhexidine-based surgical scrubs or mouthwashes, that history should be communicated to the care team before any biopatch is placed.

For most adults and older children, the patch is well tolerated. Mild skin irritation is the most common side effect. It usually resolves when the patch is removed.

How Does a Biopatch Fit Into a Central Line Bundle?

Hospitals do not rely on a biopatch alone. It is part of a set of practices called a central line bundle. These bundles are credited with large reductions in catheter-related bloodstream infections when followed consistently.

Typical bundle elements include:

• Hand hygiene before any contact with the catheter or dressing
• Maximal sterile barrier precautions during insertion — cap, mask, sterile gown, sterile gloves, full-body drape
• Skin antisepsis with chlorhexidine-based solution before insertion
• Choosing the best insertion site to reduce contamination risk
• Daily review of whether the catheter is still needed
• Prompt removal when the line is no longer necessary

The biopatch is an additional layer. It is not a substitute for any of these steps. If sterile technique breaks down, a patch will not compensate. The evidence supports the bundle as a whole more strongly than any single component.

Some hospitals use chlorhexidine-impregnated dressings instead of separate discs. These products combine the antimicrobial with the dressing itself. The principle is the same. Whether one format is superior to another is not clearly established from head-to-head trials.

What Does the Evidence Show About Biopatch Effectiveness?

Research consistently shows that chlorhexidine-impregnated discs and dressings reduce the incidence of catheter-related bloodstream infections compared with standard dressings alone. Multiple studies and meta-analyses have found a meaningful reduction, though the exact size of the benefit varies across settings and patient populations.

The evidence is strongest in intensive care settings and among patients with central lines expected to remain in place for more than a few days. For short-term lines, the benefit is smaller because there is less time for infection to develop.

Some studies suggest that chlorhexidine dressings may be more effective than standard transparent dressings but the quality of individual trials varies. The overall direction of evidence favors use, which is why many guidelines include chlorhexidine-impregnated products as part of central line care.

What the evidence does not show is that a biopatch can replace any other infection control measure. It is one component. Hospitals that have reduced infection rates to near zero have done so through consistent bundle compliance, not through any single product.

How Is a Biopatch Applied and Changed?

Application follows a specific procedure. The old dressing and any previous patch are removed. Hands are cleaned. Sterile gloves are worn. The skin around the catheter is cleaned with an appropriate antiseptic and allowed to dry completely.

The biopatch is placed with the foam side down, with the catheter sitting in the slit. A sterile transparent dressing goes over it. The patch is typically changed whenever the dressing is changed, or sooner if it becomes soiled, loose, or wet.

Chlorhexidine-impregnated discs are usually changed every three to seven days, depending on the product and hospital policy. Transparent dressings are often changed at similar intervals. If the dressing is compromised — for example, if it is wet or peeling — it should be changed right away.

Only trained healthcare providers should change a central line dressing. Home care patients and caregivers receive specific training. The risk of introducing bacteria during a dressing change is real, and technique matters more than speed.

What Are the Risks and Limitations?

The main risk is skin irritation or allergic reaction to chlorhexidine. This ranges from mild redness to rare severe reactions. Any signs of reaction should be reported to the care team.

There is also the possibility of the patch becoming dislodged or the dressing loosening. If the patch is not in contact with the skin around the catheter, it cannot do its job. Regular inspection is part of routine care.

Chlorhexidine resistance is a theoretical concern. Bacteria can develop reduced susceptibility to antiseptics over time, though this has not been clearly demonstrated to undermine the clinical effectiveness of chlorhexidine patches in practice. It remains an area of monitoring.

The biopatch does not prevent all catheter infections. Infections can also arise from contamination inside the catheter hub or from bacteria already in the bloodstream. The patch addresses only the skin entry route.